Trial Profile
In vivo induction of heme oxygenase-1 (HO-1) in the metabolic syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Dec 2021
Price :
$35
*
At a glance
- Drugs Haem arginate (Primary) ; Arginine
- Indications Metabolic syndrome
- Focus Therapeutic Use
- Acronyms MetSNS
- 20 Dec 2021 Status changed from recruiting to completed.
- 15 Sep 2010 New trial record